Buffalo BioLabs, LLC (BBL) is pleased to announce its participation in BIO International 2014, the largest and most influential biotech convention in the world, to take place in San Diego June 23-26, 2014. The BBL booth can be found at New York State Pavilion # 1559. Buffalo Biolabs, LLC (BBL), founded [...]
Buffalo Biolabs, LLC (BBL) and Incuron LLC announced today that Incuron has retained the services of Buffalo Biolabs for preclinical murine studies. The studies, to be conducted in 2014, will advance and enhance the understanding of the efficacy and mechanism of work of Incuron’s flagship compound CBLO137. According to Vladimir [...]
BUFFALO BIOLABS, LLC STRENGTHENS ITS WORKFORCE WITH NEW LABORATORY AND PRECLINICAL SERVICES PERSONNEL.
Buffalo Biolabs, LLC (BBL) and Cleveland BioLabs, Inc. (NASDAQ: CBLI) announced today that because of maturation of CBLI' development pipeline and a reduced need for certain services, it has transferred laboratory and preclinical services personnel to BBL, an entity affiliated with one of the CBLI's co-founders, Dr. Andrei Gudkov, PhD, [...]
Buffalo Biolabs, LLC (BBL) announced today that it has been awarded a phase I Small Business Technology Transfer (STTR) grant. This is a second STTR grant won by BBL. The new grant supports the work conducted by the company and its collaborators in the field of preclinical oncology. Dr. Katerina Gurova, a [...]